Myungmoon Phar Cash Flow Conversion Efficiency

Latest as of December 2025: 0.005x

Myungmoon Phar cash flow conversion efficiency. Based on the latest financial reports, Myungmoon Phar (017180) has a cash flow conversion efficiency ratio of 0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩519.72 Million ≈ $352.20K USD) by net assets (₩104.46 Billion ≈ $70.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Myungmoon Phar (2010–2025)

Cash flow conversion efficiency of Myungmoon Phar from 2010 to 2025. This chart illustrates how Myungmoon Phar's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Myungmoon Phar for real-time trading data and today's change.

Myungmoon Phar Cash Flow Conversion Ratio Explained

Myungmoon Phar cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Myungmoon Phar Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Myungmoon Phar ranked by their cash flow conversion efficiency. Also see Myungmoon Phar market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Mirae Asset Maps Reit 1 Co Ltd KO:357250	N/A
PetMed Express Inc NASDAQ:PETS	-0.164x
Seoyon Topmetal Co. Ltd KQ:019770	0.081x
Oxford Nanopore Technologies Ltd LSE:ONT	-0.093x
Boundless Bio, Inc. Common Stock NASDAQ:BOLD	-0.093x
Pamapol S.A. WAR:PMP	-0.041x
Blaize Holdings, Inc. NASDAQ:BZAI	-19.079x
Aligned Genetics Inc KQ:238120	-0.058x

Annual Cash Flow Conversion Efficiency for Myungmoon Phar (2010–2025)

The table below shows the annual cash flow conversion efficiency of Myungmoon Phar from 2010 to 2025. Review Myungmoon Phar (017180) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩104.46 Billion ≈ $70.79 Million	₩-1.70 Billion ≈ $-1.15 Million	-0.016x	-25.76%
2024-12-31	₩103.12 Billion ≈ $69.88 Million	₩-1.34 Billion ≈ $-906.54K	-0.013x	+77.78%
2023-12-31	₩88.75 Billion ≈ $60.15 Million	₩-5.18 Billion ≈ $-3.51 Million	-0.058x	-201.57%
2022-12-31	₩95.27 Billion ≈ $64.56 Million	₩5.47 Billion ≈ $3.71 Million	0.057x	+477.20%
2021-12-31	₩85.87 Billion ≈ $58.20 Million	₩855.00 Million ≈ $579.42K	0.010x	+105.42%
2020-12-31	₩90.77 Billion ≈ $61.52 Million	₩-16.67 Billion ≈ $-11.30 Million	-0.184x	-400.89%
2019-12-31	₩80.20 Billion ≈ $54.35 Million	₩-2.94 Billion ≈ $-1.99 Million	-0.037x	-129.92%
2018-12-31	₩93.06 Billion ≈ $63.07 Million	₩11.41 Billion ≈ $7.73 Million	0.123x	+55.39%
2017-12-31	₩101.72 Billion ≈ $68.93 Million	₩8.02 Billion ≈ $5.44 Million	0.079x	+33.34%
2016-12-31	₩94.68 Billion ≈ $64.16 Million	₩5.60 Billion ≈ $3.80 Million	0.059x	+172.13%
2015-12-31	₩67.12 Billion ≈ $45.49 Million	₩-5.50 Billion ≈ $-3.73 Million	-0.082x	-16457.33%
2014-12-31	₩73.15 Billion ≈ $49.57 Million	₩-36.23 Million ≈ $-24.56K	0.000x	-101.81%
2013-12-31	₩73.20 Billion ≈ $49.60 Million	₩2.00 Billion ≈ $1.36 Million	0.027x	-28.27%
2012-12-31	₩72.87 Billion ≈ $49.38 Million	₩2.78 Billion ≈ $1.88 Million	0.038x	-10.77%
2010-12-31	₩67.13 Billion ≈ $45.49 Million	₩2.87 Billion ≈ $1.95 Million	0.043x	--

About Myungmoon Phar

KO:017180 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$25.63 Million

₩37.82 Billion KRW

Market Cap Rank

#24113 Global

#1697 in Korea

Share Price

₩1114.00

Change (1 day)

-1.76%

52-Week Range

₩1057.00 - ₩1945.00

All Time High

₩10277.86